Stable expression of sialyl-Tn antigen in T47-D cells induces a decrease of cell adhesion and an increase of cell migration

Sialyl-Tn is a carbohydrate antigen overexpressed in several epithelial cancers including breast cancer, and usually associated with poor prognosis. Sialyl-Tn is synthesized by a CMP-Neu5Ac: GalNAc alpha2,6-sialyltransferase: ST6GalNAc I, which catalyzes the transfer of a sialic acid residue in alph...

Full description

Saved in:
Bibliographic Details
Published inBreast cancer research and treatment Vol. 90; no. 1; pp. 77 - 84
Main Authors JULIEN, Sylvain, LAGADEC, Chann, KRZEWINSKI-RECCHI, Marie-Ange, COURTAND, Gilles, LE BOURHIS, Xuefen, DELANNOY, Philippe
Format Journal Article
LanguageEnglish
Published Dordrecht Springer 01.03.2005
Springer Nature B.V
Springer Verlag
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Sialyl-Tn is a carbohydrate antigen overexpressed in several epithelial cancers including breast cancer, and usually associated with poor prognosis. Sialyl-Tn is synthesized by a CMP-Neu5Ac: GalNAc alpha2,6-sialyltransferase: ST6GalNAc I, which catalyzes the transfer of a sialic acid residue in alpha2,6-linkage to the GalNAcalpha1-O-Ser/Thr structure. The resulting disaccharide (Neu5Acalpha2-6GalNAcalpha1-O-Ser/Thr) cannot be further elongated and sialyl-Tn expression results therefore in a shortening of the O-glycan chains. However, usual breast cancer cell lines express neither ST6GalNAc I nor sialyl-Tn antigen. We have previously shown that stable transfection of MDA-MB-231 cells with the hST6GalNAc I cDNA induces the sialyl-Tn antigen expression at the cell surface and leads to a decreased cell growth and an increased cell migration. We describe herein the generation of new T47-D clones expressing sialyl-Tn antigen after hST6GalNAc I cDNA stable transfection. sialyl-Tn antigen is carried by several high molecular weight membrane bound O-glycoproteins, including MUC1. We show that sialyl-Tn expression induces a decrease of cell growth and adhesion, and an increase of cell migration in sialyl-Tn positive clones compared to mock transfected cells. These observations show that the alteration of the O-glycans pattern is sufficient to modify the biological features of cancer cells. These T47-D sialyl-Tn expressing clones might allow further in vivo investigation to determine precisely the impact of such O-glycosylation modifications on breast cancer development.
AbstractList Sialyl-Tn is a carbohydrate antigen overexpressed in several epithelial cancers including breast cancer, and usually associated with poor prognosis. Sialyl-Tn is synthesized by a CMP-Neu5Ac: GalNAc alpha2,6-sialyltransferase: ST6GalNAc I, which catalyzes the transfer of a sialic acid residue in alpha2,6-linkage to the GalNAcalpha1-O-Ser/Thr structure. The resulting disaccharide (Neu5Acalpha2-6GalNAcalpha1-O-Ser/Thr) cannot be further elongated and sialyl-Tn expression results therefore in a shortening of the O-glycan chains. However, usual breast cancer cell lines express neither ST6GalNAc I nor sialyl-Tn antigen. We have previously shown that stable transfection of MDA-MB-231 cells with the hST6GalNAc I cDNA induces the sialyl-Tn antigen expression at the cell surface and leads to a decreased cell growth and an increased cell migration. We describe herein the generation of new T47-D clones expressing sialyl-Tn antigen after hST6GalNAc I cDNA stable transfection. sialyl-Tn antigen is carried by several high molecular weight membrane bound O-glycoproteins, including MUC1. We show that sialyl-Tn expression induces a decrease of cell growth and adhesion, and an increase of cell migration in sialyl-Tn positive clones compared to mock transfected cells. These observations show that the alteration of the O-glycans pattern is sufficient to modify the biological features of cancer cells. These T47-D sialyl-Tn expressing clones might allow further in vivo investigation to determine precisely the impact of such O-glycosylation modifications on breast cancer development
Sialyl-Tn is a carbohydrate antigen overexpressed in several epithelial cancers including breast cancer, and usually associated with poor prognosis. Sialyl-Tn is synthesized by a CMP-Neu5Ac: GalNAc alpha2,6-sialyltransferase: ST6GalNAc I, which catalyzes the transfer of a sialic acid residue in alpha2,6-linkage to the GalNAcalpha1-O-Ser/Thr structure. The resulting disaccharide (Neu5Acalpha2-6GalNAcalpha1-O-Ser/Thr) cannot be further elongated and sialyl-Tn expression results therefore in a shortening of the O-glycan chains. However, usual breast cancer cell lines express neither ST6GalNAc I nor sialyl-Tn antigen. We have previously shown that stable transfection of MDA-MB-231 cells with the hST6GalNAc I cDNA induces the sialyl-Tn antigen expression at the cell surface and leads to a decreased cell growth and an increased cell migration. We describe herein the generation of new T47-D clones expressing sialyl-Tn antigen after hST6GalNAc I cDNA stable transfection. sialyl-Tn antigen is carried by several high molecular weight membrane bound O-glycoproteins, including MUC1. We show that sialyl-Tn expression induces a decrease of cell growth and adhesion, and an increase of cell migration in sialyl-Tn positive clones compared to mock transfected cells. These observations show that the alteration of the O-glycans pattern is sufficient to modify the biological features of cancer cells. These T47-D sialyl-Tn expressing clones might allow further in vivo investigation to determine precisely the impact of such O-glycosylation modifications on breast cancer development.
Sialyl-Tn is a carbohydrate antigen overexpressed in several epithelial cancers including breast cancer, and usually associated with poor prognosis. Sialyl-Tn is synthesized by a CMP-Neu5Ac: GalNAc 2,6-sialyltransferase: ST6GalNAc I, which catalyzes the transfer of a sialic acid residue in 2,6-linkage to the GalNAc1-O-Ser/Thr structure. The resulting disaccharide (Neu5Ac2-6GalNAc1-O-Ser/Thr) cannot be further elongated and sialyl-Tn expression results therefore in a shortening of the O-glycan chains. However, usual breast cancer cell lines express neither ST6GalNAc I nor sialyl-Tn antigen. We have previously shown that stable transfection of MDA-MB-231 cells with the hST6GalNAc I cDNA induces the sialyl-Tn antigen expression at the cell surface and leads to a decreased cell growth and an increased cell migration. We describe herein the generation of new T47-D clones expressing sialyl-Tn antigen after hST6GalNAc I cDNA stable transfection. sialyl-Tn antigen is carried by several high molecular weight membrane bound O-glycoproteins, including MUC1. We show that sialyl-Tn expression induces a decrease of cell growth and adhesion, and an increase of cell migration in sialyl-Tn positive clones compared to mock transfected cells. These observations show that the alteration of the O-glycans pattern is sufficient to modify the biological features of cancer cells. These T47-D sialyl-Tn expressing clones might allow further in vivo investigation to determine precisely the impact of such O-glycosylation modifications on breast cancer development. [PUBLICATION ABSTRACT]
Author DELANNOY, Philippe
LE BOURHIS, Xuefen
JULIEN, Sylvain
LAGADEC, Chann
COURTAND, Gilles
KRZEWINSKI-RECCHI, Marie-Ange
Author_xml – sequence: 1
  givenname: Sylvain
  surname: JULIEN
  fullname: JULIEN, Sylvain
  organization: Unité de Glycobiologie Structurale et Fonctionnelle, UMR CNRS no. 8576, GDR CNRS no. 2590, Villeneuve d'Ascq, France
– sequence: 2
  givenname: Chann
  surname: LAGADEC
  fullname: LAGADEC, Chann
  organization: Laboratoire de Biologie du Développement, INSERM ESPRI, UPRES EA 1033, Villeneuve d'Ascq, France
– sequence: 3
  givenname: Marie-Ange
  surname: KRZEWINSKI-RECCHI
  fullname: KRZEWINSKI-RECCHI, Marie-Ange
  organization: Unité de Glycobiologie Structurale et Fonctionnelle, UMR CNRS no. 8576, GDR CNRS no. 2590, Villeneuve d'Ascq, France
– sequence: 4
  givenname: Gilles
  surname: COURTAND
  fullname: COURTAND, Gilles
  organization: Centre Commun de Mesures Imagerie Cellulaire, Université des Sciences et Technologies de Lille, Villeneuve d'Ascq, France
– sequence: 5
  givenname: Xuefen
  surname: LE BOURHIS
  fullname: LE BOURHIS, Xuefen
  organization: Laboratoire de Biologie du Développement, INSERM ESPRI, UPRES EA 1033, Villeneuve d'Ascq, France
– sequence: 6
  givenname: Philippe
  surname: DELANNOY
  fullname: DELANNOY, Philippe
  organization: Unité de Glycobiologie Structurale et Fonctionnelle, UMR CNRS no. 8576, GDR CNRS no. 2590, Villeneuve d'Ascq, France
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16638130$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/15770530$$D View this record in MEDLINE/PubMed
https://hal.science/hal-00086279$$DView record in HAL
BookMark eNpd0U9rFDEUAPAgLXZb_QBeJAgVPERfJv9mjqWttrDgwfUc3mSSdspsZk1mxOKXb8ZdLPQQQpJfXl7eOyVHcYyekHccPnMA8yVzULJhAJIJLgwTr8iKKyOYqbg5Iivg2jBdgz4hpzk_AEBjoHlNTgoyoASsyN8fE7aDp_7PLvmc-zHSMdDc4_A4sE2kGKf-zkfaR7qRhl1R54chl2U3O58p0s675DH75dpyRrG79__iYOzKKPQF2PZ3Caci3pDjgEP2bw_zGfn59XpzecPW37_dXl6smZNKT6xG4wTwIEFr0dRcggiNaJVCoWqpdeDGSDCe1xCC5K4T0Eoj2tC0qq0qIc7Ip33cexzsLvVbTI92xN7eXKztslcKU-vKNL95sR_3dpfGX7PPk932eUkbox_nbLVRVdWoBX54AR_GOcXyD1vxSkoJUhbE98ilMefkw__nOdilhXbfwpKBtEsL7ZLt-0Pgud367vnGoWcFnB8AZodDSBhdn59dqVLNi3sC13aiTQ
CODEN BCTRD6
CitedBy_id crossref_primary_10_1016_j_ijbiomac_2024_129318
crossref_primary_10_1371_journal_pone_0099026
crossref_primary_10_1038_sj_embor_7400705
crossref_primary_10_3390_biom5031783
crossref_primary_10_1016_j_coi_2005_11_001
crossref_primary_10_1155_2015_792672
crossref_primary_10_3390_metabo2040913
crossref_primary_10_1016_j_canlet_2006_08_010
crossref_primary_10_1016_j_canlet_2013_10_005
crossref_primary_10_1158_1078_0432_CCR_05_0729
crossref_primary_10_3390_cells9020446
crossref_primary_10_1038_sj_bjc_6605083
crossref_primary_10_1038_s41598_018_30421_w
crossref_primary_10_1093_glycob_cwj033
crossref_primary_10_1016_j_carres_2010_01_024
crossref_primary_10_1194_jlr_M026955
crossref_primary_10_18632_oncotarget_6024
crossref_primary_10_1007_s10555_012_9359_7
crossref_primary_10_1186_s12943_015_0386_1
crossref_primary_10_1002_ijc_21959
crossref_primary_10_1051_medsci_2021082
crossref_primary_10_3390_cancers14235840
crossref_primary_10_18632_oncotarget_17138
crossref_primary_10_1007_s12156_010_0035_2
crossref_primary_10_1016_j_bbagen_2016_01_002
crossref_primary_10_1093_glycob_cwj045
crossref_primary_10_1007_s10719_023_10104_z
crossref_primary_10_1016_j_molonc_2013_03_001
crossref_primary_10_1016_j_bbagen_2014_06_006
crossref_primary_10_1042_BCJ20170205
crossref_primary_10_1158_1541_7786_MCR_07_2209
crossref_primary_10_1016_j_biopha_2024_116619
crossref_primary_10_1007_s00018_012_1082_6
crossref_primary_10_1042_BJ20140060
crossref_primary_10_1146_annurev_pathol_012414_040438
crossref_primary_10_1158_2159_8290_CD_13_0287
crossref_primary_10_3390_biom2040435
crossref_primary_10_3389_fonc_2016_00055
crossref_primary_10_1080_19420862_2017_1290752
crossref_primary_10_1002_anie_201002313
crossref_primary_10_1016_j_ebiom_2019_01_017
crossref_primary_10_1016_j_bbagen_2016_03_008
crossref_primary_10_1083_jcb_201003055
crossref_primary_10_1111_vco_12586
crossref_primary_10_1002_bit_26952
crossref_primary_10_1038_s41598_018_29209_9
crossref_primary_10_18632_oncotarget_11257
crossref_primary_10_3390_biom6040039
crossref_primary_10_1016_j_canlet_2017_07_026
crossref_primary_10_1099_vir_0_044396_0
crossref_primary_10_1002_ange_201002313
crossref_primary_10_1186_bcr2577
crossref_primary_10_3390_biom12060743
crossref_primary_10_3390_cancers14081854
Cites_doi 10.1091/mbc.7.4.565
10.1093/glycob/9.11.1213
10.1023/A:1022200525695
10.1385/1-59259-137-X:033
10.1002/(SICI)1097-0215(19980504)76:3<377::AID-IJC15>3.0.CO;2-8
10.1016/S0304-4165(00)00020-9
10.1083/jcb.129.1.255
10.1074/jbc.272.39.24198
10.1016/S0925-4439(99)00055-1
10.1016/1040-8428(94)90053-1
10.1007/s005350170124
10.1002/(SICI)1097-0142(19971215)80:12<2240::AID-CNCR4>3.0.CO;2-Y
10.1002/path.1430
10.1053/hupa.2000.9776
10.1016/0014-5793(81)80134-2
10.1007/s005950070004
10.1007/BF02484401
10.1083/jcb.200212033
10.1006/gyno.1999.5708
10.1016/S0344-0338(96)80148-8
10.1023/A:1018580324971
10.1016/S0021-9258(19)84610-0
10.1177/172460080001500413
10.1074/jbc.M202921200
10.1042/bj2270155
10.1007/BF00203391
10.1006/bbrc.2000.2745
10.1002/1097-0215(20001115)88:4<507::AID-IJC1>3.0.CO;2-0
10.1002/(SICI)1096-9896(199608)179:4<358::AID-PATH564>3.0.CO;2-T
ContentType Journal Article
Copyright 2005 INIST-CNRS
Springer 2005
Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: 2005 INIST-CNRS
– notice: Springer 2005
– notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7TO
7X7
7XB
88E
8AO
8C1
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
H94
K9-
K9.
M0R
M0S
M1P
M2O
MBDVC
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
1XC
DOI 10.1007/s10549-004-3137-3
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Oncogenes and Growth Factors Abstracts
ProQuest_Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
AIDS and Cancer Research Abstracts
Consumer Health Database
ProQuest Health & Medical Complete (Alumni)
ProQuest Consumer Health Database
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
ProQuest_Research Library
Research Library (Corporate)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
Hyper Article en Ligne (HAL)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Research Library Prep
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
AIDS and Cancer Research Abstracts
ProQuest Research Library
ProQuest Medical Library (Alumni)
ProQuest Public Health
ProQuest Central Basic
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
Research Library Prep
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1573-7217
EndPage 84
ExternalDocumentID oai_HAL_hal_00086279v1
815881631
10_1007_s10549_004_3137_3
15770530
16638130
Genre Evaluation Studies
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-XW
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
199
1N0
1SB
2.D
203
23N
28-
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3O-
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5VS
67Z
6NX
78A
7X7
88E
8AO
8C1
8FI
8FJ
8G5
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AABYN
AAFGU
AAHNG
AAIAL
AAJKR
AAKSU
AANXM
AANZL
AAPBV
AARHV
AARTL
AATNV
AATVU
AAUYE
AAWCG
AAYFA
AAYIU
AAYQN
AAYTO
ABBBX
ABBXA
ABDZT
ABECU
ABFGW
ABFTV
ABHLI
ABHQN
ABIPD
ABJOX
ABKAS
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACBMV
ACBRV
ACBXY
ACBYP
ACGFS
ACHSB
ACHVE
ACHXU
ACIGE
ACIHN
ACIPQ
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPRK
ACTTH
ACUDM
ACVWB
ACWMK
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADMDM
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEAQA
AEBTG
AEEQQ
AEFIE
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFAFS
AFDYV
AFEXP
AFFNX
AFJLC
AFKRA
AFLOW
AFNRJ
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGGDS
AGJBK
AGKHE
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AJZVZ
AKMHD
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BKNYI
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
DWQXO
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
GQ8
GRRUI
GUQSH
GXS
H13
HF~
HG5
HG6
HMJXF
HQYDN
HRMNR
HZ~
I09
IAO
ICW
IHE
IHR
IHW
IJ-
IKXTQ
IMOTQ
INH
INR
IQODW
ITC
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
K9-
KDC
KOV
KOW
KPH
LAK
LLZTM
M0R
M1P
M2O
M4Y
MA-
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RNI
ROL
RPX
RRX
RSV
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UDS
UG4
UKHRP
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
YLTOR
Z45
Z7U
Z7W
Z7X
Z81
Z82
Z83
Z87
Z8O
Z8Q
Z8U
Z8V
Z8W
Z91
ZGI
ZMTXR
ZOVNA
ZXP
~EX
~KM
AACDK
AAEOY
AAJBT
AASML
AAYZH
ABAKF
ABJNI
ACAOD
ACDTI
ACZOJ
AEFQL
AEMSY
AFBBN
AGQEE
AGRTI
AIGIU
AJOOF
ALIPV
CGR
CUY
CVF
ECM
EIF
HMCUK
HVGLF
NPM
AAYXX
CITATION
7TO
7XB
8FK
H94
K9.
MBDVC
PQEST
PQUKI
PRINS
Q9U
7X8
1XC
ID FETCH-LOGICAL-c456t-8a7c301f40663981403f93b55a358466f177407e180ff41cd30b473bf9b5b2233
IEDL.DBID 8C1
ISSN 0167-6806
IngestDate Tue Oct 15 15:19:53 EDT 2024
Sat Aug 17 02:04:42 EDT 2024
Thu Oct 10 16:36:41 EDT 2024
Thu Sep 12 19:24:12 EDT 2024
Tue Oct 15 23:29:15 EDT 2024
Sun Oct 22 16:08:39 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Carbohydrate antigen
Tumor associated antigen
O-glycosylation
Glycosylation
Tumoral marker
Breast cancer
Malignant tumor
Gene expression
Adhesion
In vitro
ST6GalNAc I
sialyl-Tn
Mammary gland diseases
Cell motility
migration
Cell migration
breast Cancer
Sialyl-Tn
cell adhesion
Language English
License CC BY 4.0
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c456t-8a7c301f40663981403f93b55a358466f177407e180ff41cd30b473bf9b5b2233
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-6796-9815
PMID 15770530
PQID 212444044
PQPubID 36266
PageCount 8
ParticipantIDs hal_primary_oai_HAL_hal_00086279v1
proquest_miscellaneous_67522951
proquest_journals_212444044
crossref_primary_10_1007_s10549_004_3137_3
pubmed_primary_15770530
pascalfrancis_primary_16638130
PublicationCentury 2000
PublicationDate 2005-03-01
PublicationDateYYYYMMDD 2005-03-01
PublicationDate_xml – month: 03
  year: 2005
  text: 2005-03-01
  day: 01
PublicationDecade 2000
PublicationPlace Dordrecht
PublicationPlace_xml – name: Dordrecht
– name: Netherlands
PublicationTitle Breast cancer research and treatment
PublicationTitleAlternate Breast Cancer Res Treat
PublicationYear 2005
Publisher Springer
Springer Nature B.V
Springer Verlag
Publisher_xml – name: Springer
– name: Springer Nature B.V
– name: Springer Verlag
References T Lesuffleur (CR28) 1994; 17
I Brockhausen (CR11) 2001; 382
B Davidson (CR36) 2000; 31
B Samyn-Petit (CR10) 2000; 1474
E Dabelsteen (CR1) 1996; 179
Mensdorff-Pouilly von (CR27) 2000; 15
J Taylor-Papadimitriou (CR29) 1994; 1455
Wesseling J (CR32) 1995; 129
B Davidson (CR19) 2000; 77
AY Kinney (CR35) 1997; 80
R Soares (CR18) 1996; 192
S M ller (CR21) 2002; 277
Y Ikehara (CR8) 1999; 127
T Suwa (CR33) 1998; 76
JC Paulson (CR7) 1989; 264
Y Cao (CR3) 1996; 106
T Nakagoe (CR16) 2001; 36
T Nakagoe (CR15) 2002; 22
RA McIlhinney (CR23) 1985; 227
M Kono (CR9) 2000; 272
Y Ikehara (CR12) 1999; 9
AS Wong (CR26) 2003; 161
MJ Ligtenberg (CR31) 1992; 52
Y Kim (CR2) 1997; 14
Y Manabe (CR25) 2003; 201
CR4
MD Burdick (CR5) 1997; 272
CR6
Y Takano (CR14) 2000; 30
S Satoh (CR34) 2000; 88
RT Vaessen (CR22) 1981; 124
Wesseling J (CR30) 1996; 7
CR24
S Julien (CR20) 2001; 18
T Imada (CR13) 1999; 46
FC Schmitt (CR17) 1995; 427
References_xml – volume: 7
  start-page: 565
  year: 1996
  ident: CR30
  publication-title: Mol Biol Cell
  doi: 10.1091/mbc.7.4.565
  contributor:
    fullname: Wesseling J
– volume: 9
  start-page: 1213
  year: 1999
  ident: CR12
  publication-title: Glycobiology
  doi: 10.1093/glycob/9.11.1213
  contributor:
    fullname: Y Ikehara
– volume: 18
  start-page: 883
  year: 2001
  ident: CR20
  publication-title: Glycoconj J
  doi: 10.1023/A:1022200525695
  contributor:
    fullname: S Julien
– ident: CR24
  doi: 10.1385/1-59259-137-X:033
– volume: 76
  start-page: 377
  year: 1998
  ident: CR33
  publication-title: Int J Cancer
  doi: 10.1002/(SICI)1097-0215(19980504)76:3<377::AID-IJC15>3.0.CO;2-8
  contributor:
    fullname: T Suwa
– volume: 1474
  start-page: 201
  year: 2000
  ident: CR10
  publication-title: Biochim Biophys Acta
  doi: 10.1016/S0304-4165(00)00020-9
  contributor:
    fullname: B Samyn-Petit
– volume: 129
  start-page: 255
  year: 1995
  ident: CR32
  publication-title: J Cell Biol
  doi: 10.1083/jcb.129.1.255
  contributor:
    fullname: Wesseling J
– volume: 272
  start-page: 24198
  year: 1997
  ident: CR5
  publication-title: J Biol Chem
  doi: 10.1074/jbc.272.39.24198
  contributor:
    fullname: MD Burdick
– volume: 52
  start-page: 2318
  year: 1992
  ident: CR31
  publication-title: Cancer Res
  contributor:
    fullname: MJ Ligtenberg
– ident: CR4
– volume: 1455
  start-page: 301
  year: 1994
  ident: CR29
  publication-title: Biochim. Biophys Acta
  doi: 10.1016/S0925-4439(99)00055-1
  contributor:
    fullname: J Taylor-Papadimitriou
– ident: CR6
– volume: 17
  start-page: 153
  year: 1994
  ident: CR28
  publication-title: Crit Rev Oncol Hematol
  doi: 10.1016/1040-8428(94)90053-1
  contributor:
    fullname: T Lesuffleur
– volume: 22
  start-page: 451
  year: 2002
  ident: CR15
  publication-title: Anticancer Res
  contributor:
    fullname: T Nakagoe
– volume: 46
  start-page: 208
  year: 1999
  ident: CR13
  publication-title: Hepato-gastroenterology
  contributor:
    fullname: T Imada
– volume: 36
  start-page: 166
  year: 2001
  ident: CR16
  publication-title: J Gastroenterol
  doi: 10.1007/s005350170124
  contributor:
    fullname: T Nakagoe
– volume: 80
  start-page: 2240
  year: 1997
  ident: CR35
  publication-title: Cancer
  doi: 10.1002/(SICI)1097-0142(19971215)80:12<2240::AID-CNCR4>3.0.CO;2-Y
  contributor:
    fullname: AY Kinney
– volume: 201
  start-page: 221
  year: 2003
  ident: CR25
  publication-title: J Pathol
  doi: 10.1002/path.1430
  contributor:
    fullname: Y Manabe
– volume: 31
  start-page: 1081
  year: 2000
  ident: CR36
  publication-title: Hum Pathol
  doi: 10.1053/hupa.2000.9776
  contributor:
    fullname: B Davidson
– volume: 124
  start-page: 193
  year: 1981
  ident: CR22
  publication-title: FEBS Lett
  doi: 10.1016/0014-5793(81)80134-2
  contributor:
    fullname: RT Vaessen
– volume: 30
  start-page: 1073
  year: 2000
  ident: CR14
  publication-title: Surg Today
  doi: 10.1007/s005950070004
  contributor:
    fullname: Y Takano
– volume: 106
  start-page: 197
  year: 1996
  ident: CR3
  publication-title: Histochem Cell Biol
  doi: 10.1007/BF02484401
  contributor:
    fullname: Y Cao
– volume: 161
  start-page: 1191
  year: 2003
  ident: CR26
  publication-title: J Cell Biol
  doi: 10.1083/jcb.200212033
  contributor:
    fullname: AS Wong
– volume: 77
  start-page: 35
  year: 2000
  ident: CR19
  publication-title: Gynecol Oncol
  doi: 10.1006/gyno.1999.5708
  contributor:
    fullname: B Davidson
– volume: 127
  start-page: 845
  year: 1999
  ident: CR8
  publication-title: J Biochem
  contributor:
    fullname: Y Ikehara
– volume: 192
  start-page: 1181
  year: 1996
  ident: CR18
  publication-title: Pathol Res Pract
  doi: 10.1016/S0344-0338(96)80148-8
  contributor:
    fullname: R Soares
– volume: 14
  start-page: 569
  year: 1997
  ident: CR2
  publication-title: Glycoconj. J
  doi: 10.1023/A:1018580324971
  contributor:
    fullname: Y Kim
– volume: 264
  start-page: 17615
  year: 1989
  ident: CR7
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(19)84610-0
  contributor:
    fullname: JC Paulson
– volume: 382
  start-page: 219
  year: 2001
  ident: CR11
  publication-title: Biol Chem
  contributor:
    fullname: I Brockhausen
– volume: 15
  start-page: 343
  year: 2000
  ident: CR27
  publication-title: Int J Biol Marker
  doi: 10.1177/172460080001500413
  contributor:
    fullname: Mensdorff-Pouilly von
– volume: 277
  start-page: 26103
  year: 2002
  ident: CR21
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M202921200
  contributor:
    fullname: S M ller
– volume: 227
  start-page: 155
  year: 1985
  ident: CR23
  publication-title: Biochem J
  doi: 10.1042/bj2270155
  contributor:
    fullname: RA McIlhinney
– volume: 427
  start-page: 251
  year: 1995
  ident: CR17
  publication-title: Virchows Arch
  doi: 10.1007/BF00203391
  contributor:
    fullname: FC Schmitt
– volume: 272
  start-page: 94
  year: 2000
  ident: CR9
  publication-title: Biochem Biophys Res Commun
  doi: 10.1006/bbrc.2000.2745
  contributor:
    fullname: M Kono
– volume: 88
  start-page: 507
  year: 2000
  ident: CR34
  publication-title: Int J Cancer
  doi: 10.1002/1097-0215(20001115)88:4<507::AID-IJC1>3.0.CO;2-0
  contributor:
    fullname: S Satoh
– volume: 179
  start-page: 359
  year: 1996
  ident: CR1
  publication-title: J Pathol
  doi: 10.1002/(SICI)1096-9896(199608)179:4<358::AID-PATH564>3.0.CO;2-T
  contributor:
    fullname: E Dabelsteen
SSID ssj0009709
Score 2.099246
Snippet Sialyl-Tn is a carbohydrate antigen overexpressed in several epithelial cancers including breast cancer, and usually associated with poor prognosis. Sialyl-Tn...
SourceID hal
proquest
crossref
pubmed
pascalfrancis
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 77
SubjectTerms Antigens
Antigens, Tumor-Associated, Carbohydrate - metabolism
Biochemistry, Molecular Biology
Biological and medical sciences
Biomarkers, Tumor - metabolism
Breast cancer
Breast Neoplasms - metabolism
Cancer research
Cell Adhesion
Cell adhesion & migration
Cell Line, Tumor - metabolism
Cell Movement
Glycosylation
Gynecology. Andrology. Obstetrics
Humans
Life Sciences
Mammary gland diseases
Medical sciences
Sialyltransferases - metabolism
Tumors
Title Stable expression of sialyl-Tn antigen in T47-D cells induces a decrease of cell adhesion and an increase of cell migration
URI https://www.ncbi.nlm.nih.gov/pubmed/15770530
https://www.proquest.com/docview/212444044
https://search.proquest.com/docview/67522951
https://hal.science/hal-00086279
Volume 90
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fa9swED6WFsZgjP2e2y0TY08DMWmSLflpdF1LGGsZI4W8CcmW2kLnZHM6OvrP9852EjrYHvxgW5bxfXfSd9L5DuCtrmPhvYo8BGG5LqPhPiXFhQ4J_Q1fha7G0tFxMTnRX2b5bIjNaYewytWY2A3U9byiNfL3H2gi0kLrj4ufnIpG0ebqUEFjBNsS9ZIqN9j9TYRHafoID0rtXVhRrDY1-z_n0DHiFIWhpEIzuzUtjc4oKPL-wrcop9QXuPg3A-1mosOH8GCgkGyvx_wR3InNY7h7NGySP4FrJJDhIrJ4NQS5NmyeWIuK9ueCTxuGsqQUnOy8YVNt-GdGi_ctntYIc8s8qzsq2UZ6jO4xX5_Frh_f1Hhg078a_Dg_7TXpKZwcHkz3J3yoscArpE5Lbr2p0MaTJupRUvorlUoV8twroiZFksgPhYnSipS0rGolgjYqpDLkAamFegZbzbyJL4CZZEUdkGCJ2mibUEVDWalcWhN1kLLK4N1KxG7Rp9Jwm6TJhIdDPBzh4VQGbxCEdTtKgj3Z--roWu-GmfK3zGB8C6NNt_gxFmfnDHZXoLnBNlu31qQMXq_volGRvHwT55etQy-KypzjC573SG96zo3BcUvs_LfnXbjXpXjtYtVewtby12V8heRlGcYwMjMz7hR1DNufDo6_fb8BTs_r1g
link.rule.ids 230,315,786,790,891,12083,12250,21416,27955,27956,31752,31753,33299,33300,33777,33778,43343,43612,43838,74100,74369,74657
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT9swED4BkzakadpPyBhgTXuaZM3BTpw8TQiGytbyVKS-WXZsDyRICylo0_753SVpKyaNhzwkcRzlvjv7O_tyB_BJ-ZBbKwN3ThRclUFzG6PkQrmI_oatXFtjaXSWD87V90k26WNzmj6scjEmtgO1n1a0Rv7lgCYiJZT6OrvhVDSKNlf7Chrr8ERJqUjN9USvcu7qLsKDUnvnhcgXm5rdn3PoGHGKwpCpRDN7MC2tX1BQ5POZbVBOsStw8X8G2s5EJy_hRU8h2WGH-StYC_VreDrqN8nfwB8kkO4qsPCrD3Kt2TSyBhXt9xUf1wxlSSk42WXNxkrzY0aL9w2eeoS5YZb5lko2gR6je8z6i9D2Y2uPBzb9p8H15c9Ok97C-cm38dGA9zUWeIXUac4Lqyu08aiIepSU_krGUross5KoSR5T5IdCh7QQMaq08lI4paWLpcscUgv5DjbqaR22gelYCO-QYAmvVRFRRV1ZySwtdFAuTasEPi9EbGZdKg2zSppMeBjEwxAeRibwEUFYtqMk2IPDoaFrnRumy_s0gb0HGK26xY8pcHZOYGcBmultszFLTUpgf3kXjYrkZeswvWsMelFU5hxfsNUhveo50xrHLfH-0Z734dlgPBqa4enZjx3YbNO9tnFrH2BjfnsXdpHIzN1eq65_AekX7Ho
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwED6xTZqQEOI3YbBZiCckaw524uQJDbaqwFZNqJP2ZtmxzSaNtJAOgfjnuUvcVkOChzwkcS6K7-z7zr58B_BK-VBaKwN3TlRc1UFzG6PkQrmI8YZtXF9j6WRSjs_Ux_PiPFEKdSmtcjkn9hO1nzW0Rr7_hhyREkrtx5QVcXo4ejv_xqmAFG20pmoaG7ClVVlgHLb17mhy-nnNwKuHfA8i-i4rUS63OIf_6DBM4pSTIXOJg-6Gk9q4oBTJO3PbYa_FodzFv_Fo75dG9-BuApTsYLCA-3ArtA9g-yRtmT-E3wgn3VVg4WdKeW3ZLLIOze7XFZ-2DHuWCDnZZcumSvNDRkv5HZ56VHrHLPM9sOwCPUb3mPUXoZdjW48HNv2rwdfLL4NdPYKz0dH0_Zinigu8QSC14JXVDY74qAiI1ESGJWMtXVFYSUCljDmiRaFDXokYVd54KZzS0sXaFQ6BhnwMm-2sDU-B6VgJ7xBuCa9VFdFgXd3IIq90UC7PmwxeL7vYzAdiDbOmUCZ9GNSHIX0YmcFLVMKqHVFijw-ODV0bgjJd_8gz2L2ho7VY_JgKfXUGO0ulmTRSO7Oyqwz2VndxiFF_2TbMrjuDMRUVPccXPBk0vZZcaI2zmHj2X8l7sI22ao4_TD7twO2e-7VPYnsOm4vv1-EFopqF2032-gdnAPId
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Stable+expression+of+sialyl-Tn+antigen+in+T47-D+cells+induces+a+decrease+of+cell+adhesion+and+an+increase+of+cell+migration&rft.jtitle=Breast+cancer+research+and+treatment&rft.au=Julien%2C+Sylvain&rft.au=Lagadec%2C+Chann&rft.au=Krzewinski-Recchi%2C+Marie-Ange&rft.au=Courtand%2C+Gilles&rft.date=2005-03-01&rft.pub=Springer+Verlag&rft.issn=0167-6806&rft.eissn=1573-7217&rft.volume=90&rft.spage=77&rft.epage=84&rft_id=info:doi/10.1007%2Fs10549-004-3137-3&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=oai_HAL_hal_00086279v1
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0167-6806&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0167-6806&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0167-6806&client=summon